Thrombospondins: Multifunctional regulators of cell interactions

Annual Review of Cell and Developmental Biology

Volumn 17, Issue , 2001, Pages 25-51

  Adams, J C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Adhesion; Angiogenesis; Cytoskeleton; Extracellular matrix; Signaling

Indexed keywords

THROMBOSPONDIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; APOPTOSIS; CELL ADHESION; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; CELL SHAPE; CONFERENCE PAPER; CYTOSKELETON; EXTRACELLULAR MATRIX; HUMAN; KNOCKOUT MOUSE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VERTEBRATE;

ANIMALS; BACTERIAL PROTEINS; CELL ADHESION MOLECULES; CELL COMMUNICATION; CULTURE TECHNIQUES; CYTOSKELETAL PROTEINS; EXTRACELLULAR MATRIX; GENE EXPRESSION; HUMANS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; THROMBOSPONDINS; TRANSFERASES; VERTEBRATES;

VERTEBRATA;

EID: 0035178990     PISSN: 10810706     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.cellbio.17.1.25     Document Type: Conference Paper

References (172)

1. Activation of platelet transforming growth factor-betal in the absence of TSP-1
2. Formation of stable microspikes containing actin and the 55 kDa actin bundling protein, fascin, is a consequence of cell adhesion to thrombospondin-1: Implications for the anti-adhesive activities of thrombospondin-1
3. Thrombospondin-1
4. Characterization of cell-matrix adhesion requirements for the formation of fascin microspikes
5. Cell-matrix contact structures
6. Cell-matrix adhesions differentially regulate fascin phosphorylation
7. The kelch repeat superfamily of proteins: Propellers of cell function
8. A role for syndecan-1 in coupling fascin spike formation by thrombospondin-1
9. Diverse mechanisms for cell attachment to platelet thrombospondin
10. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1
11. Stimulation of fascin spikes by thrombospondin-1 is mediated by the GTPases Rac and Cdc42
12. Muskelin, a novel intracellular mediator of cell adhesive and cytoskeletal responses to thrombospondin-1
13. The thrombospondin type 1 repeat (TSR) superfamily: Diverse proteins with related roles in neuronal development
14. Relative abundance of thrombospondin 2 and thrombospondin 3 mRNA in human tissues
15. Thrombospondin-4, an extracellular matrix protein expressed in the developing and repairing nervous system promotes neurite outgrowth
16. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding
17. Effects of thrombospondin on fibrin polymerization and structure
18. The three-dimensional structure of the first EGF-like module of human factor IX: Comparison with EGF and TGF-alpha
19. Thrombospondin type 1 repeats interact with matrix metalloproteinase 2. Regulation of metalloproteinase activity
20. Extracellular compartments in tendon morphogenesis: Collagen fibril, bundle and macroaggregate formation
21. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or TSP-1 overexpression through halted tumor vasculature
22. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin-1
23. Thrombospondin-2, a matricellular protein with diverse functions
24. Isolation and characterization of the mouse thrombospondin 3 (Thbs3) gene
25. A second thrombospondin gene in the mouse is similar in organization to thrombospondin-1 but does not respond to serum
26. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene
27. Integrin-associated protein is an adhesive receptor on sickle red blood cels for immobilised thrombospondin
28. Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated alpha3betal integrin and regulated by IGF-1 and CD98
29. Properties of recombinant mouse thrombospondin-2 expressed in Spodoptera cells
30. Antibody blockade of thrombospondin accelerates reendothelialization and reduces neointima formation in balloon-injured rat carotid artery
31. Vascular smooth muscle cell growth arrest on blockade of thrombospondin-1 requires p21Cipl/WA F1
32. Cartilage oligomeric matrix protein is a calcium-binding protein, and a mutation in its type 3 repeats causes conformational changes
33. Expression and initial characterization of recombinant mouse thrombospondin 1 and thrombospondin 3
34. Metabolism of TSP-2. Binding and degradation by 3T3 cells and glycosaminoglycan-variant Chinese hamster ovary cells
35. Expression profiling in the muscular dystrophies: Identification of novel aspects of molecular pathophysiology
36. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: The Johnston County Osteoarthritis project
37. Colocalization of thrombospondin and syndecan during murine development
38. Thrombospondin-1 is a major activator of TGF-β1 in vivo
39. Bovine thrombospondin-1: Complete cDNA sequence and immunolocalization in the external zones of the adrenal cortex
40. Physiological and pathological secretion of cartilage oligomeric matrix protein by cells in culture
41. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon
42. Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding
43. The thrombospondin-like chains of cartilage oligomeric matrix protein are assembled by a five-stranded alpha-helical bundle between residues 20 and 83
44. Bone dysplasias in man: Molecular insights
45. Evidence for sequential appearance of cartilage matrix proteins in developing mouse limbs and in cultures of mouse mesenchymal cells
46. Structural study of the sugar chains of human platelet thrombospondin-1
47. Thrombospondin-1 induces activation of focal adhesion kinase in vascular smooth muscle cells
48. Thrombospondin-1 regulation of smooth muscle cell chemotaxis is extracellular signal-regulated protein kinases 1/2 dependent
49. Cell adhesion to a motif shared by the malarial circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG
50. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin
51. Thrombospondin-1 induces tyrosine phosphorylation of adherens junctions proteins and regulates an endothelial paracellular pathway
52. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
53. Thrombospondin signalling of focal adhesion disassembly requires activation of phosphoinositide 3-kinase
54. Restructuring of focal adhesion plaques by PI 3-kinase: Regulation by PtdIns (3, 4, 5)-P3 binding to α-actinin
55. Thrombospondin-1 and type 1 repeat peptides of TSP-1 specifically induce apoptosis of endothelial cells
56. Heparin-binding motifs from the type 1 repeats of thrombospondin. Structural requirements for heparin-binding and promotion of melanoma cell adhesion and chemotaxis
57. All-trans retinol, vitamin D and other hydrophobic compounds bind in the axial pore of the five-stranded coiled-coil domain of COMP
58. Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin-2
59. Tendon extracellular matrix contains pentameric thrombospondin-4
60. Characterization of cartilage oligomeric matrix protein (COMP) in human normal and pseudoachodroplasia musculoskeletal tissues
61. Retention of cartilage oligomeric matrix protein (COMP) and cell death in redifferentiated pseudoachondroplasia chondrocytes
62. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia
63. Immunolocalization of TSP-1 in human, bovine and rat cornea
64. Unexpected expression of TSP-1 by corneal and iris fibroblasts in the pseudoexoliation syndrome
65. Expression of TSP-1 by adult lens epithelium
66. Thrombospondin expression in nerve regeneration I. Comparison of sciatic nerve crush, transection, and long-term denervation
67. C-mannosylation and O-fucosylation of the thrombospondin type 1 module
68. Thrombospondin 1 as an enzyme inhibitor
69. Identification of possible inhibitory reactive centers in TSP-1 that may bind cathepsin G and neutrophil elastase
70. Cartilage oligomeric matrix protein interacts with type IX collagen; disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family
71. Exposure of the cryptic Arg-Gly-Asp sequence in thrombospondin-1 by protein disulphide isomerase
72. Delta 469 mutation in the type 3 repeat calcium binding domain of cartilage oligomeric matrix protein disrupts calcium binding
73. Differential expression of thrombospondins 1, 2, and 3 during murine development
74. Inhibition of angiogenesis by TSP-1 is mediated by two independent regions in the type 1 repeats
75. Signals leading to apoptosis-dependent inhibition of neovascularisation by thrombospondin-1
76. Tip-mediated fusion involving unipolar collagen fibrils accounts for rapid fibril elongation, the occurrence of fibrillar branched networks in skin and the paucity of collagen fibril ends in vertebrates
77. Heparin-binding growth associated molecule contains two heparin-binding β-sheet domains that are homologous to the thrombospondin type 1 repeat
78. Molecular cloning and expression patterns of mouse cartilage oligomeric matrix protein gene
79. Identification of an alpha3 beta 1 integrin recognition sequence in TSP-1
80. Persistent high serum levels of cartilage oligomeric matrix protein in a subgroup of patients with traumatic knee injury
81. Mice that lack the angiogenesis inhibitor, thrombospondin-2, mount an altered foreign body reaction characterized by increased vascularity
82. Accelerated wound healing in mice with a disruption of the thrombospondin-2 gene
83. Mice that lack thrombospondin-2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density and a bleeding diathesis
84. The distribution of the matricellular protein TSP-2 in tissues of embryonic and adult mice
85. Thrombospondin II: Partial cDNA sequence, chromosome location, and expression of a second member of the thrombospondin gene family in humans
86. Characterization of mouse thrombospondin-2 sequence and expression during cell growth and development
87. The functions of thrombospondin-1 and-2
88. The structure of human platelet thrombospondin
89. Identification and characterization of thrombospondin-4, a new member of the thrombospondin family
90. Expression and mutagenesis of thrombospondin
91. The structure of human thrombospondin, an adhesive glycoprotein with multiple calcium binding sites and homologies with several different proteins
92. An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin
93. Characterization of human thrombospondin-4
94. Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia
95. Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation
96. The fate of cartilage oligomeric matrix protein is determined by the cell type in the case of a novel mutation in pseudoachondroplasia
97. A cartilage oligomeric matrix protein mutation associated with pseudoachondroplasia changes the structural and functional properties of the type 3 domain
98. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation
99. The crystal structure of a five-stranded coiled coil in COMP: A prototype ion channel?
100. Decorin inhibits cell attachment to TSP-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of TSP-1
101. Smooth muscle cell immediate-early gene and growth factor activation follows vascular injury
102. Low density lipoprotein receptor-related protein mediates the cellular internalization and degradation of thrombospondin. A process facilitated by cell-surface proteoglycans
103. Calcium ion binding to thrombospondin-1
104. Physical characterization of the procollagen module of human thrombospondin-1 expressed in insect cells
105. Regulation of thrombospondin in the regenerating mouse facial motor nucleus
106. Fringe is a glycosyltransferase that modifies Notch
107. Electron microscopy of native cartilage oligomeric matrix protein purified from the Swarm rat chondrosarcoma reveals a five-armed structure
108. COMP (cartilage oligomeric matrix protein) is synthesized in ligament, tendon, meniscus, and articular cartilage
109. Thrombospondin modulates focal adhesions in endothelial cells
110. Heparin-binding peptides from TSP-1 and TSP-2 contain focal-adhesion labilizing activity
111. Localization of thrombospondin in clots formed in sim
112. Altered metabolism of thrombospondin by Chinese hampster ovary cells defective in glycosaminoglycan synthesis
113. Thrombospondin-4 binds specifically to both collagenous and non-collagenous matrix proteins via its C-terminal domains
114. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation
115. Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway
116. COMP is structurally related to the thrombospondins
117. Unique distribution of the extracellular matrix component thrombospondin in the developing mouse embryo
118. Interaction of recombinant procollagen and properdin modules of thrombospondin-1 with heparin and fibrinogen/fibrin
119. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint
120. Thrombospondin 3 is a pentameric molecule held together by interchain disulfide linkage involving two cysteine residues
121. Thrombospondin 3 is a developmentally regulated heparin-binding protein
122. Thrombospondin deposition in rat carotid artery injury
123. Thrombospondin in early human wound tissue
124. The activation sequence of TSP-1 interacts with the latency associated peptide to regulate activation of latent transforming growth factor-beta
125. Cartilage oligomeric matrix protein is expressed by human vascular smooth muscle cells
126. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen
127. Thrombospondin-1 is elevated with both intimal hyperplasia and hypercholesterolemia
128. 3 integrins, nonmuscle myosin heavy chain-A and focal adhesion kinase form in thrombospondin-treated smooth muscle cells
129. Electron spin resonance and fluorescence studies of the conformational environment of the thiol groups of thrombospondin: Interactions with thrombin
130. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis
131. Regulation of transforming growth factor beta activation by discrete sequences of thrombospondin-1
132. Inhibition of retinal angiogenesis by peptides derived from thrombospondin
133. Targeted disruption of the mouse transforming growth factor-1 gene results in multifocal inflammatory disease
134. Inhibition of fibronectin-binding and fibronectin-mediated cell adhesion to collagen by a peptide from the second type 1 repeat of thrombospondin
135. Neutron and X-ray scattering studies on the human complement protein properdin provide an analysis of the thrombospondin repeat
136. Synthesis of truncated amino terminal trimers of thrombospondin
137. Free thiols of platelet thrombospondin. Evidence for disulfide isomerization
138. 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response
139. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP)
140. Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis
141. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas
142. Thrombospondin-1 suppresses wound healing and granulation tissue formation in the skin of transgenic mice
143. Heparan sulfate-mediated binding of epithelial cell surface proteoglycan to thrombospondin
144. Disulphides modulate RGD-inhibitable cell adhesive activity of thrombospondin
145. Mutations in cartilage oligomeric matrix protein (COMP) causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I,II and IX
146. Integrin-associated protein (CD47/IAP) contributes to T cell arrest on inflammatory vascular endothelium under flow
147. Peptides derived from two separate domains of the ma trix protein TSP-1 have anti-angiogenic activity
148. Restricted localization of TSP-2 protein during mouse embryogenesis: A comparison to TSP-1
149. The in situ localization of tenascin splice variants and TSP-2 mRNA in the avian embryo
150. Thrombospondin-4 is expressed by early osteogenic tissues in the chick embryo
151. In situ localization of thrombospondin-1 and thrombospondin-3 transcripts in the avian embryo
152. Thrombospondis in early Xenopus embryos: Dynamic patterns of expression suggest diverse roles in the nervous system notochord and muscle development
153. Central role of TSP-1 in the activation and clonal expansion of inflammatory T cells
154. Association of thrombospondin of endothelial cells with other matrix proteins and cell attachment sites and migration tracks
155. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1
156. Inhibition of angiogenesis by thrombospondin-2
157. Thrombospondin 3 (Thbs3), a new member of the thrombospondin gene family
158. The thrombospondin receptor CD47/IAP modulates and associates with α2β1 integrin in vascular smooth muscle cells
159. Integrin-associated protein stimulates α2β1-integrin-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinases
160. Thrombospondin expression in traumatized skeletal muscle. Correlation of appearance with post-trauma regeneration
161. Transfection of TSP-1 cDNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential and angiogenesis
162. Inhibition of phosphatidylinositol 3-kinase and protein kinase C attenuates extracellular matrix protein-induced vascular smooth muscle cell chemotaxis
163. β1 integrin and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by TSP-1 and TSP-1 peptides
164. Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3
165. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor
166. Activated T-cell adhesion to TSP-1 is mediated by the VLA-4 and VLA-5 integrins
167. Thrombospondin mediates migration and potentiates PDGF-dependent migration of calf pulmonary artery smooth muscle cells
168. Matrix cellular proteins as modulators of cell-matrix interactions: Adhesive defect in thrombospondin-2-null fibroblasts is a consequence of increased levels of matrix metalloproteinase 2
169. Extracellular MMP2 levels are regulated by the LRP scavenger receptor and thrombospondin-2
170. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires TSP-1 and its cell-surface receptor CD36